RNF145 and neoplasm: RNF145 and TRC8 inhibit SREBP2 activation via SCAP ubiquitination or ER-to-Golgi transport blockade. USP28 promotes tumor growth by stabilizing SREBP2, enhancing cholesterol metabolism.